Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 68

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 1
Chunk 68
---
 FINANCIAL STATEMENTS (Continued)

 Weighted-Average Amortization Life in YearsJune 30, 2025 CostAccumulatedAmortizationNetPatents10$38,718 $24,148 $14,570 Customer contracts1210,202 7,300 2,902 Non-contractual customer relationships8563,987 273,327 290,660 Trademarks15,425 5,425 — Trade name1518,245 8,967 9,278 Developed technology(1) 10627,611 262,023 365,588 Non-compete39,100 9,100 — Total amortized intangible assets $1,273,288 $590,290 $682,998 Internally developed software(2) $15,011 $15,011 Total intangible assets$1,288,299 $590,290 $698,009 ______________________________ (1)    Developed technology primarily consists of acquired patented technologies and internally developed software. Upon completion of development, the assets are amortized over their estimated useful lives. (2)    Internally developed software will be reclassified to developed technology and amortized when the projects are complete and the assets are ready for their intended use. Weighted-Average Amortization Life in YearsDecember 31, 2024 CostAccumulatedAmortizationNetPatents10$36,811 $22,913 $13,898 Customer contracts129,818 6,994 2,824 Non-contractual customer relationships8546,404 236,267 310,137 Trademarks15,425 5,425 — Trade name1518,239 8,357 9,882 Developed technology(1) 10619,540 227,869 391,671 Non-compete39,100 9,100 — Total amortized intangible assets $1,245,337 $516,925 $728,412 Internally developed software(2) $12,377 $12,377 Total intangible assets$1,257,714 $516,925 $740,789 _______________________________(1)    Developed technology primarily consists of acquired patented technologies and internally developed software. Upon completion of development, the